Abstract:BACKGROUND:Non-alcoholic fatty liver disease (NAFLD) is the most prevalent form of chronic liver diseases. Cyclocarya paliurus (C. paliurus), an edible and medicinal plant in Chinese folk, has been demonstrated to ameliorate diabetes, obesity and lipid metabolism disorders. However, its effects on NAFLD and its potential molecular mechanism have not been clearly expounded.PURPOSE:The present study was designed to explore the therapeutic potential of triterpenic acids-enriched fraction from C. paliurus (CPT), as well as its underlying mechanism in vivo and in vitro models of NAFLD.METHODS:The metabolic effects and possible molecular mechanism of CPT were examined using HepG2 cells and primary hepatocytes (isolated from C57BL/6 J mice) models of fatty liver induced by palmitic acid (PA) and a high fat diet mouse model.RESULTS:In high fat diet-induced C57BL/6 J mice, CPT significantly reduced liver weight index, serum alanine transaminase (ALT), aspartate transaminase (AST), triacylglycerol (TG), total cholesterol (TC) and hepatic TG, TC levels. Moreover, CPT dramatically decreased the contents of blood glucose, insulin, and insulin resistance (HOMA-IR) index. Meanwhile, CPT significantly increased the tyrosine phosphorylation level of IRS and the uptake of 2-deoxyglucose (2DG) in PA-induced HepG2 cells and primary hepatocytes fatty liver models. Furthermore, in PA-induced HepG2 cells and primary hepatocytes, CPT significantly decreased the number of lipid droplets and intracellular TG content. In addition, mechanism investigation showed that CPT increased the phosphorylation of phosphoinositide 3-kinase (PI3K), protein kinase B (Akt) and glycogen synthase-3β (GSK3β) in vivo and in vitro models, which were abrogated by PI3K inhibitor LY294002 in vitro models.CONCLUSION:These findings indicate that CPT may exert the therapeutic effects on NAFLD via regulating PI3K/Akt/GSK3β pathway.

Pentacyclic Triterpenoids from Cyclocarya Paliurus and Their Antioxidant Activities in FFA-induced HepG2 Steatosis Cells.

Triterpenoids from Cyclocarya paliurus and their inhibitory effect on the secretion of apoliprotein B48 in Caco-2 cells

Intervention effects of the triterpenoids from Cyclocarya paliurus on free fatty acids-induced steatosis in HepG2 cells

Triterpenoids from Cyclocarya Paliurus That Enhance Glucose Uptake in 3T3-L1 Adipocytes

Growth and Triterpenic Acid Accumulation of Cyclocarya Paliurus Cell Suspension Cultures

Cyclocarioside O-Q, three novel seco-dammarane triterpenoid glycosides from the leaves of Cyclocarya paliurus

Antihyperlipidaemic Effect of Triterpenic Acid-Enriched Fraction from Cyclocarya Paliurus Leaves in Hyperlipidaemic Rats

New triterpenoids from the Cyclocarya paliurus (Batalin) Iljinskaja and their anti-fibrotic activity

New Cycloartane Triterpenes from the Aerial Parts of Cimicifuga Heracleifolia

Hypoglycemic triterpenoid glycosides from Cyclocarya paliurus (Sweet Tea Tree)

Bioactive pentacyclic triterpenoids from the whole plants of Pterocephalus hookeri

Two new triterpenoids from the leaves of Cyclocarya paliurus (Batalin) Iljinskaja

Structurally Diverse Glycosides with Α-Glucosidase Inhibitory Properties from Water Extract of the Leaves of Cyclocarya Paliurus

Oxygenated pentacyclic triterpenoids from the stems and branches of Enkianthus chinensis

Three New Ursane-Type Triterpenoids From The Stems Of Saprosma Merrillii

Triterpenoids from Cyclocarya Paliurus: Structure, Biosynthesis, Biological Activities

Triterpene esters of cirsium setosum and their anti-inflammatory activity

Bioactive dammarane triterpenoid saponins from the leaves of Cyclocarya paliurus

Triterpenoids from the Leaves of Cyclocarya paliurus and Their Glucose Uptake Activity in 3T3-L1 Adipocytes

A norsesquiterpene lactone and a benzoic acid derivative from the leaves of Cyclocarya paliurus and their glucosidase and glycogen phosphorylase inhibiting activities.

Triterpenic Acids-Enriched Fraction from Cyclocarya Paliurus Attenuates Insulin Resistance and Hepatic Steatosis Via PI3K/Akt/GSK3β Pathway